150 related articles for article (PubMed ID: 35140782)
21. Soluble syndecan-1 as marker of intestinal inflammation: A preliminary study and evaluation of a new panel of biomarkers for non-invasive prediction of active ulcerative colitis.
Floer M; Clausen M; Meister T; Vollenberg R; Bettenworth D; Tepasse PR
Adv Clin Exp Med; 2021 Jul; 30(7):655-660. PubMed ID: 34286513
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of serum procalcitonin in patients with ulcerative colitis.
Koido S; Ohkusa T; Takakura K; Odahara S; Tsukinaga S; Yukawa T; Mitobe J; Kajihara M; Uchiyama K; Arakawa H; Tajiri H
World J Gastroenterol; 2013 Dec; 19(45):8335-41. PubMed ID: 24363525
[TBL] [Abstract][Full Text] [Related]
23. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
[TBL] [Abstract][Full Text] [Related]
24. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.
Fluxá D; Simian D; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Castro M; Piottante A; Vial MT; Quera R
J Dig Dis; 2017 Nov; 18(11):634-641. PubMed ID: 28949435
[TBL] [Abstract][Full Text] [Related]
25. Monocyte/High-Density Lipoprotein Ratio Is an Indicator of Activity in Patients with Ulcerative Colitis.
Yalçın MS; Yalaki S; Ölmez Ş; Taş A
Turk J Gastroenterol; 2022 Apr; 33(4):329-335. PubMed ID: 35550541
[TBL] [Abstract][Full Text] [Related]
26. Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission.
Guardiola J; Lobatón T; Rodríguez-Alonso L; Ruiz-Cerulla A; Arajol C; Loayza C; Sanjuan X; Sánchez E; Rodríguez-Moranta F
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1865-70. PubMed ID: 24993368
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis.
Hassan EA; Ramadan HK; Ismael AA; Mohamed KF; El-Attar MM; Alhelali I
Saudi J Gastroenterol; 2017; 23(4):238-245. PubMed ID: 28721978
[TBL] [Abstract][Full Text] [Related]
28. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis.
Shentova R; Baycheva M; Hadjiiski P; Kofinova D; Yaneva P
Gastroenterol Hepatol; 2020 Jan; 43(1):57-61. PubMed ID: 31733888
[TBL] [Abstract][Full Text] [Related]
29. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
[TBL] [Abstract][Full Text] [Related]
30. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
[TBL] [Abstract][Full Text] [Related]
31. Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis.
Hart L; Chavannes M; Kherad O; Maedler C; Mourad N; Marcus V; Afif W; Bitton A; Lakatos PL; Brassard P; Bessissow T
J Crohns Colitis; 2020 Jan; 14(1):46-52. PubMed ID: 31314884
[TBL] [Abstract][Full Text] [Related]
32. Further research on the clinical relevance of the ulcerative colitis colonoscopic index of severity for predicting 5-year relapse.
Ishida N; Onoue S; Miyazu T; Tamura S; Tani S; Yamade M; Iwaizumi M; Hamaya Y; Osawa S; Furuta T; Sugimoto K
Int J Colorectal Dis; 2021 Dec; 36(12):2661-2670. PubMed ID: 34409500
[TBL] [Abstract][Full Text] [Related]
33. Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.
Berry N; Sinha SK; Bhattacharya A; Prasad KK; Vaishnavi C; Vaiphei K; Samanta J; Prasada R; Dhaka N; Kochhar R
Dig Dis Sci; 2018 Jun; 63(6):1541-1550. PubMed ID: 29564671
[TBL] [Abstract][Full Text] [Related]
34. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis.
Ikeya K; Sugimoto K; Kawasaki S; Iida T; Maruyama Y; Watanabe F; Hanai H
Dig Liver Dis; 2015 May; 47(5):365-71. PubMed ID: 25682993
[TBL] [Abstract][Full Text] [Related]
35. How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system.
Bálint A; Farkas K; Szepes Z; Nagy F; Szűcs M; Tiszlavicz L; Bor R; Milassin Á; Rutka M; Fábián A; Molnár T
BMC Gastroenterol; 2018 Jan; 18(1):7. PubMed ID: 29310593
[TBL] [Abstract][Full Text] [Related]
36. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
Walsh A; Kormilitzin A; Hinds C; Sexton V; Brain O; Keshav S; Uhlig H; Geddes J; Goodwin G; Peters M; Collins G; Travis S
J Crohns Colitis; 2019 Mar; 13(4):424-430. PubMed ID: 30445625
[TBL] [Abstract][Full Text] [Related]
37. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis.
Yamaguchi S; Takeuchi Y; Arai K; Fukuda K; Kuroki Y; Asonuma K; Takahashi H; Saruta M; Yoshida H
J Gastroenterol Hepatol; 2016 Jan; 31(1):93-8. PubMed ID: 26212346
[TBL] [Abstract][Full Text] [Related]
38. Assessment of disease activity by fecal immunochemical test in ulcerative colitis.
Ryu DG; Kim HW; Park SB; Kang DH; Choi CW; Kim SJ; Nam HS
World J Gastroenterol; 2016 Dec; 22(48):10617-10624. PubMed ID: 28082814
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL study.
Samaan MA; Cunningham G; Tamilarasan AG; Beltran L; Pavlidis P; Ray S; Mawdsley J; Anderson SH; Sanderson JD; Arkir Z; Irving PM
Aliment Pharmacol Ther; 2020 Jul; 52(2):292-302. PubMed ID: 32506695
[TBL] [Abstract][Full Text] [Related]
40. Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin.
Kristensen V; Klepp P; Cvancarova M; Røseth A; Skar V; Moum B
J Crohns Colitis; 2015 Feb; 9(2):164-9. PubMed ID: 25518057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
